Publication: Orthopedics Today

First reported 3 hours ago - Updated 3 hours ago - 1 reports

Top 4 glaucoma surgery videos

The emergence of technologies for the treatment of glaucoma continue to set the stage for further approaches that target patients with the condition.Minimally-invasive transscleral glaucoma surgery techniques and stab incision glaucoma surgery have taken ... [Published Orthopedics Today - 3 hours ago]
First reported 8 hours ago - Updated 8 hours ago - 1 reports

New app engages patients in fight against obesity chronic disease

The tech startup 3Pound Health announced recently the commercial release of its health, weight and lifestyle management program, Euco.“Clinician-patient interaction is such a critical part of achieving a weight-loss goal,” Wendy Scinta, MD, private practice ... [Published Orthopedics Today - 8 hours ago]
First reported 17 hours ago - Updated 17 hours ago - 1 reports

AHA grant will help promote CV health for high-risk children

Four US institutions have been named an American Heart Association Strategically Focused Prevention Research Network Center and received a $15 million grant to promote CV health among high-risk children and their caregivers.The grant was awarded to the ... [Published Orthopedics Today - 17 hours ago]
First reported 21 hours ago - Updated 21 hours ago - 1 reports

Amedica reaches $26 million funding, debt financing agreement

Amedica Corporation announced it has secured up to $26 million in additional funding.The funding consists of $20 million in debt financing from Hercules Technology Growth Capital, as well as a private placement to MG Partners II of 6% senior convertible ... [Published Orthopedics Today - 21 hours ago]
First reported Jul 27 2014 - Updated Jul 27 2014 - 1 reports

Nonsurgical option available for long-standing or sensory strabismus in adults

In this News You Can Use from UPMC Eye Center publication exclusive, Lea Ann Lope, DO, at Children’s Hospital of Pittsburgh, provides insight into the use of Botox to treat strabismus in adults.With Botox, improvements in the position of the eye can be ... [Published Orthopedics Today - Jul 27 2014]
First reported Jul 27 2014 - Updated Jul 27 2014 - 1 reports

Investigational pancreatic cancer drug trial resumes patient enrollment, dosing

Halozyme Therapeutics recently announced that it has resumed enrollment and dosing of patients in its Study 202 trial, evaluating its investigational pegylated formulation of recombinant human hyaluronidase in pancreatic cancer, under a revised clinical ... [Published Orthopedics Today - Jul 27 2014]
First reported Jul 26 2014 - Updated Jul 26 2014 - 1 reports

ATA announces grants with help from Bite Me Cancer and ThyCa

The American Thyroid Association is teaming up with Bite Me Cancer , a thyroid cancer patient support group, to deliver a newly awarded grant in medullary thyroid cancer research.The American Thyroid Association (ATA) has also announced three grants as ... [Published Orthopedics Today - Jul 26 2014]
First reported Jul 26 2014 - Updated Jul 26 2014 - 1 reports

Trial will evaluate efficacy of combined drug-releasing balloon, self-expanding stent

Enrollment has started for the BIOLUX 4EVER trial, which will assess the combined use of a drug-releasing balloon and a self-expanding stent for the treatment of superficial femoral artery lesions, according to a press release.The trial will enroll 120 ... [Published Orthopedics Today - Jul 26 2014]
First reported Jul 26 2014 - Updated Jul 26 2014 - 1 reports

Thermedx granted 510(k) clearance for arthroscopic fluid warming system

Thermedx has received U.S. Food and Drug Administration 510(k) clearance for the FluidSmart System, which provides optional fluid warming in arthroscopic and hysteroscopic procedures.As the only company with FDA clearance to provide optional fluid warming, ... [Published Orthopedics Today - Jul 26 2014]
First reported Jul 26 2014 - Updated Jul 26 2014 - 1 reports

Nexavar fails to meet primary endpoint in HER-2–negative breast cancer

Results from a phase 3 trial have found that sorafenib plus capecitabine did not meet its primary endpoint of improving PFS for the treatment of locally advanced or metastatic HER-2–negative breast cancer, manufacturers Bayer HealthCare Pharmaceuticals ... [Published Orthopedics Today - Jul 26 2014]
First reported Jul 24 2014 - Updated Jul 25 2014 - 2 reports

Reality television helped adults at risk for diabetes to lose weight

Watching evidence-based diabetes prevention programming in the form of reality television could encourage weight loss for adults at risk for diabetes, according to research published in Obesity .Offered alone or backed by online behavioral support, in-home ... [Published Orthopedics Today - Jul 25 2014]
First reported Jul 25 2014 - Updated Jul 25 2014 - 2 reports

BLOG: Managing associate optometrists in your practice, part 3

Hiring a new optometrist — or properly managing the doctors you have — should start with a position description. This should include the following elements:Scope of practiceThe practice’s optometrists will practice to the highest levels permitted by state ... [Published Orthopedics Today - Jul 25 2014]

Quotes

...brimonidine, like prostaglandin analogs, would reduce nighttime IOP because of its effects on uveoscleral was not proven true," they continued. "A shorter duration of action of brimonidine as compared with prostaglandins may be a contributory factor. Had a dose been administered at 1 a.m., a nighttime IOP reduction might have been detected."
...of retinal blood flow to structural damage of the optic nerve head between African descent and European descent patients," the authors wrote. "These data indicate the strong probability that alterations to retinal capillary blood flow may be more apparent in open-angle glaucoma patients of African descent compared to their European descent counterparts and may help explain non IOP-related relative risk."
...proof of concept studies of aramchol in the United States in the future," Allen Baharaff, chief executive officer at Galmed, said in the release. "We further believe that the indications we are seeking to address with aramchol are increasingly relevant public health issues as they are major causes of cardiovascular and liver-related morbidity and mortality, with no approved treatment currently available."

More Content

All (864) | News (864) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Top 4 glaucoma surgery videos [Published Orthopedics Today - 3 hours ago]
New app engages patients in fight against obesi... [Published Orthopedics Today - 8 hours ago]
AHA grant will help promote CV health for high-... [Published Orthopedics Today - 17 hours ago]
Amedica reaches $26 million funding, debt finan... [Published Orthopedics Today - 21 hours ago]
Nonsurgical option available for long-standing ... [Published Orthopedics Today - Jul 27 2014]
Investigational pancreatic cancer drug trial re... [Published Orthopedics Today - Jul 27 2014]
ATA announces grants with help from Bite Me Can... [Published Orthopedics Today - Jul 26 2014]
Thermedx granted 510(k) clearance for arthrosco... [Published Orthopedics Today - Jul 26 2014]
Trial will evaluate efficacy of combined drug-r... [Published Orthopedics Today - Jul 26 2014]
Nexavar fails to meet primary endpoint in HER-2... [Published Orthopedics Today - Jul 26 2014]
Boehringer Ingelheim accused of withholding saf... [Published Orthopedics Today - Jul 26 2014]
Dermoscopic features of basal cell carcinoma be... [Published Orthopedics Today - Jul 26 2014]
Take Steps fundraiser supports research on indi... [Published Orthopedics Today - Jul 25 2014]
Bowel health campaign promotes dialogue about f... [Published Orthopedics Today - Jul 25 2014]
Cosmetic transcutaneous lower blepharoplasty re... [Published Orthopedics Today - Jul 25 2014]
ViiV offers additional funds to pediatric HIV p... [Published Orthopedics Today - Jul 25 2014]
Most pathogens identified within 24 hours in fe... [Published Orthopedics Today - Jul 25 2014]
USPSTF: Not enough evidence to warrant vitamin ... [Published Orthopedics Today - Jul 25 2014]
Major infections worsened mortality rates in pa... [Published Orthopedics Today - Jul 25 2014]
Drug paraphernalia activates different brain ar... [Published Orthopedics Today - Jul 25 2014]
Ocular Therapeutix prices initial public offeri... [Published Orthopedics Today - Jul 25 2014]
Topical tamoxifen noninferior to oral version f... [Published Orthopedics Today - Jul 25 2014]
Gilead anticipates expansion of HBV, HIV drug i... [Published Orthopedics Today - Jul 25 2014]
Sofosbuvir/ribavirin showed minimal effect on h... [Published Orthopedics Today - Jul 25 2014]
Efficacy similar for infliximab, cyclosporine i... [Published Orthopedics Today - Jul 25 2014]
Pain, itching indicate different forms of skin ... [Published Orthopedics Today - Jul 25 2014]
Incidence, death rates on decline for HIV, mala... [Published Orthopedics Today - Jul 25 2014]
AAO announces 2014 award winners [Published Orthopedics Today - Jul 25 2014]
Study: Brimonidine significantly reduces daytim... [Published Orthopedics Today - Jul 25 2014]
European authorities recommend marketing extens... [Published Orthopedics Today - Jul 25 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.